Research identity
TB-500 / thymosin-beta-4 pathway
A transparent review of identity, animal research, veterinary relevance and the limits of direct canine evidence.
What PET157 looks for
Direct canine outcomes, canine safety and pharmacokinetic evidence, relevant animal models, human investigational work, formulation identity and regulatory status are reviewed separately.
What remains unknown
The evidence described on this page does not establish clinical efficacy for this compound or formulation in canine patients. Species differences, formulation, route, stability and study quality all limit how far findings can be carried into practice.